(Q73369641)
Statements
Reumacon (CPH82) showed similar x-ray progression and clinical effects as methotrexate in a two year comparative study on patients with early rheumatoid arthritis (English)
Reumacon (CPH82) showed similar x‐ray progression and clinical effects as methotrexate in a two year comparative study on patients with early rheumatoid arthritis (English)
1 reference
1 reference
1 reference
Holger Pettersson
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference